𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retention of inhaled perfluoroisobutene in the rat

✍ Scribed by M. P. Maidment; D. G. Upshall


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
656 KB
Volume
12
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Perfluoroisobutene (PFIB) is produced by the pyrolysis, and as a by‐product during the manufacture, of polytetrafluoroethylene. When inhaled it produces a fulminating and sometimes fatal pulmonary oedema similar to that of phosgene after a latent period of 6–8 h. As part of a study to determine the retained dose and the factors that control the amount retained, this study has investigated the retention in rats of inhaled PFIB at concentrations of 10, 50 and 250 ΞΌg l^βˆ’1^ in a flow‐through system combining head‐only exposure and plethysmography. Uptake of PFIB was measured by gas chromatography during elevated and reduced inspired volume and respiratory rate induced by exposure to increased CO^2^and injection of pentobarbitone, respectively. The percentage of PFIB retained in the upper airways and lungs was found to be 27.5, 28.1 and 23.7% of the amount inspired at the three concentrations tested. The rate of uptake (nmol min^βˆ’1^ kg^βˆ’1^) of PFIB was a power law of the amount inhaled, an n^b^‐fold increase in minute volume producing an n‐fold increase in uptake, where b varied between 0.4 and 0.85. Thus, doubling the inhaled dose produces a 1.3–1.8‐fold increase in uptake with a corresponding decrease in percentage retained. The relative contribution of respiratory rate and tidal volume upon PFIB retention could not be defined.


πŸ“œ SIMILAR VOLUMES


Retention of inhaled hexafluorocyclobute
✍ M. P. Maidment; P. Rice; D. G. Upshall πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 541 KB

Hexafluorocyclobutene (HFCB), a cyclic analogue of perfluoroisobutene (PFIB), is a reactive gas that induces a fulminating pulmonary oedema in rats from which animals may die after an apparently asymptomatic period between 24 and 30 h, depending on the dose. To determine the dose of inhaled gas to t